Alternatives to Randomized Trials for Estimating Treatment Efficacy (or Harm) Thomas B. Newman, MD, MPH Professor of Epidemiology and Biostatistics and Pediatrics, UCSF AltToRcts31Oct06
56
Embed
Alternatives to Randomized Trials for Estimating Treatment Efficacy (or Harm) Thomas B. Newman, MD, MPH Professor of Epidemiology and Biostatistics and.
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Slide 1
Alternatives to Randomized Trials for Estimating Treatment
Efficacy (or Harm) Thomas B. Newman, MD, MPH Professor of
Epidemiology and Biostatistics and Pediatrics, UCSF
AltToRcts31Oct06
Slide 2
Lecture Outline n Prelude Announcements Double gold standard
bias n Background n Instrumental variables and natural experiments
n Measuring additional unrelated variables to estimate bias n
Propensity scores n Illustration using phototherapy for
jaundice
Slide 3
Announcements n Handouts: Chapter 11, problems, this
presentation n Exam question contest: questions due Thurs, 11/9/06
by e-mail to TN Real examples only, recent articles strongly
preferred Include answer We may change it n Take-home final will be
handed out 11/16, discussed in class 11/30
Slide 4
Double Gold Standard Bias Revisited n Test: ultrasound n
Disease: Intussusception n 2 different gold standards. Air contrast
enema Observation/follow-up n As long is there is no spontaneous
resolution the two gold standards give the same answer n
Spontaneous resolution gives + BE and F/U
Slide 5
Suppose spontaneous resolution occurs n In q cases with + U/S n
In r cases with U/S n BE will be + for q and r n F/U will be for q
and r
Slide 6
Effect of double gold-standard
Slide 7
Alternatives to Randomized Trials for Estimating Treatment
Efficacy (or Harm) Thomas B. Newman, MD, MPH Professor of
Epidemiology and Biostatistics and Pediatrics, UCSF
AltToRcts31Oct06
Slide 8
Background n Why do RCTs? Assemble comparable groups (avoid
confounding) Allow blinding (to avoid placebo effect,
cointerventions, and bias in measuring outcome variable) n
Observational studies May be able to assemble comparable groups or
use statistical adjustment Wont be blinded
Slide 9
Why is it hard to assemble comparable groups without
randomizing? n People who get treated differ from those who dont n
Important differences are with respect risk of the outcome Treated
people often at higher risk (confounding by indication for
treatment). Treated people may be at lower risk (selection
bias)
Slide 10
Pre-test n Observational studies can never establish causation.
Proof of causation requires randomized trials. n How many have
heard this? n How many agree?
Slide 11
Do you believe there is a causal relationship between n
Acetaminophen overdose or mushroom poisoning and liver failure? n
Wearing glasses for refractive errors and improved vision? n
Infiltrate of IV calcium infusion and skin sloughing? n Receipt of
fluids and recovery from dehydration? n Land mine explosions and
limb injuries?
Slide 12
Post-test n Observational studies can never establish
causation. Proof of causality requires randomized trials. n How
many agree?
Slide 13
When is causal inference from observational studies easy? n
Outcomes not related to indications for treatment rarely if ever
occurs spontaneously highly localized in time or space n Treatment
well-understood biologically very rapidly acting
Slide 14
When its hard: n Outcomes are related to indications or
selection for treatment, are delayed, non specific, or not well
understood Learning disabilities in children treated with
anticonvulsants Suicide in users of antidepressants Mortality after
surgery for gastroesophageal reflux in children
Slide 15
Natural Experiments and Instrumental Variables n Find a time or
place where receipt of treatment was unlikely to be related to
prognosis E.g., time-series analyses where something changed (e.g.
new intervention became available) n Instrumental variables (IV):
measurable factors that influence probability of treatment that are
not otherwise associated with outcome
Slide 16
Use of large databases n Allows use of (weak) surrogate
measures for actual predictor n Biased towards null n Achieve
statistical significance with large sample size n Algebraically
reverse bias towards null (with various assumptions)
Slide 17
Delayed Effects of the Military Draft on Mortality n Origin of
study: Agent Orange concern n Design: Randomized natural experiment
using the draft lottery n Data source: computerized death
certificate registries, CA and PA n Predictor variable of interest:
military service Hearst N, Newman TB, Hulley SB. NEJM 1986;
314:620-24
Slide 18
Why not compare outcomes according to the predictor variable of
interest? n Biased comparison those who serve in the military start
out healthier n Healthy warrior effect
Slide 19
Delayed Effects of the Military Draft on Mortality n The
instrumental variable measured: draft lottery number below cutoff
(based on date of birth) n IV associated with predictor variable of
interest, not independently associated with outcome
Slide 20
BUT: Having an eligible number was a poor measure of military
service:
Slide 21
Results
Slide 22
RCT as an Instrumental Variable: Health effects of exclusive
breast feeding n Cant do RCT of exclusive breast-feeding n Can do
RCT of breast-feeding PROMOTION n Assignment to BF promotion group
should be associated with exclusive breast feeding, but not
independently associated with outcome n Need very large sample size
n Algebraic correction
Slide 23
Promotion of Breastfeeding Intervention Trial (PROBIT) n
Cluster-randomized trial at 31 sites in Belarus n Subjects 17,046
term singleton infants >2500g initially breastfed n
Intervention: WHO/UNICEF Baby Friendly Hospital Initiative n
Outcomes: BF @ 3,6,9,12 months and allergic, gastrointestinal and
respiratory disease n F/U to 12 months on 16,491 (96.7%) Kramer MS,
et al. JAMA 2001;285:413-20.
Slide 24
PROBIT, RQ #1 n Does a Baby Friendly Hospital increase
exclusive breastfeeding? Predictor = Group assignment Outcome =
Exclusive breast feeding Intention-to-treat (ITT) analysis is fine
n Exclusive BF at 3 months (rounded) 40% vs 5%; P < 0.001
Slide 25
Probit RQ#2 n Does exclusive breastfeeding reduce the risk of
eczema in the infant? n If the only effect of intervention related
to eczema is increasing exclusive BF, then Predictor = Group
assignment Outcome = Eczema ITT analysis: biased towards null;
informative if study positive n Eczema 3.3% vs 6.3%; adjusted OR =
0.54 (95% CI 0.31-.95 based on GLIMMIX; P = 0.03)
Slide 26
PROBIT, RQ#3 n How much does exclusive breastfeeding reduce the
risk of eczema in the infant? (What is the NNEBF*? ) Predictor =
Group assignment Outcome = Eczema ITT wont work -- too much
misclassification. (Gives the number needed to be exposed to the
intervention, not the NNEBF.) *Number Needed Exclusively to Breast
Feed
Slide 27
Algebraic correction n If all of the difference in eczema is
due to the difference in exclusive breast feeding, it can be shown
that the ARR is
Slide 28
NNEBF and caveat n Since ARR = 8.6%, NNEBF to prevent 1 case of
eczema is about 1/.086 = 12 n Caveats: Results are for the effect
of breastfeeding in response to the intervention Assumes the only
effect of the Baby Friendly Hospital is via difference in exclusive
breastfeeding n Similarly, effects of draft lottery only apply to
those who served as a result of the lottery.
Slide 29
Summary/other examples n If variables known NOT to be
associated with outcome are associated with treatment of interest,
consider this approach. n Generalizes to manynatural experiments.
E.g., an intervention is intermittently available, or only
available to certain groups. -- different outcome by day of the
week, etc.
Slide 30
More natural experiments: n Costs of discontinuity of care:
increased laboratory test ordering in patients transferred to a
different team the next morning* n Effect of ER Copay: rate of
appendicitis perforation unchanged after increase in co- pay.** n
Aircraft cabin air recirculation and symptoms of the common cold:
no difference by type of air recirculation in aircraft *** *
Lofgren, RO. J Gen Intern Med. 1990;5:501-5 **Hsu J, et al.
Presented at Bay Area Clinical Research Symposium 10/17/03 ***
Zitter JN et al. JAMA 2002;288:483-6
Slide 31
Unrelated variables to estimate bias or confounding n Measure
an outcome that WOULD be affected by bias, but not by intervention
(and see if it is) n Measure a predictor that WOULD cause the same
bias as the predictor of interest (and see if it does)
Slide 32
Observational study of screening sigmoidoscopy n Possible bias:
patients who agree to sigmoidoscopy are likely to be different n
Solution: measure an outcome that would be similarly affected by
bias n Results: Decreased deaths from cancers within the reach of
the sigmoidoscope (OR= 0.41) No effect on deaths from more proximal
cancers (OR= 0.96). Selby et al, NEJM 1992;326:653-7
Slide 33
Effect of British breathalyser crackdown n Abrupt drop in
accidents occurring during weekend nights (when pubs are open) n
Measure an outcome that would be affected by bias: accidents during
other times n Result: No change in accidents occurring during other
hours See Cook and Campbell: Quasi- Experimentation.Boston:Houghton
Mifflin, p. 219
Slide 34
Calcium Channel Blockers (CCB) and AMI n Population based
case-control study at Group Health n Progressive increase in risk
of AMI with higher doses of CCB (P